In the last three months, 13 analysts have published ratings on Allstate ALL, offering a diverse range of perspectives from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 7 | 3 | 3 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 3 | 2 | 1 | 0 | 0 |
| 2M Ago | 1 | 0 | 1 | 0 | 0 |
| 3M Ago | 3 | 1 | 0 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $159.69, a high estimate of $193.00, and a low estimate of $138.00. This upward trend is apparent, with the current average reflecting a 15.57% increase from the previous average price target of $138.18.
Analyzing Analyst Ratings: A Detailed Breakdown
A comprehensive examination of how financial experts perceive Allstate is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Michael Zaremski | BMO Capital | Raises | Market Perform | $158.00 | $140.00 |
| Brian Meredith | UBS | Raises | Buy | $171.00 | $160.00 |
| Andrew Kligerman | TD Cowen | Announces | Outperform | $193.00 | - |
| Alex Scott | Goldman Sachs | Raises | Buy | $164.00 | $141.00 |
| Yaron Kinar | Jefferies | Raises | Buy | $180.00 | $130.00 |
| Michael Phillips | Morgan Stanley | Raises | Overweight | $171.00 | $117.00 |
| Vikram Gandhi | HSBC | Announces | Hold | $145.00 | - |
| Michael Zaremski | BMO Capital | Raises | Market Perform | $140.00 | $125.00 |
| Brian Meredith | UBS | Raises | Buy | $160.00 | $152.00 |
| Alex Scott | Goldman Sachs | Raises | Buy | $141.00 | $128.00 |
| C. Gregory Peters | Raymond James | Raises | Strong Buy | $155.00 | $145.00 |
| Nicole Miller Regan | Piper Sandler | Raises | Overweight | $138.00 | $137.00 |
| Harry Fong | Roth MKM | Raises | Buy | $160.00 | $145.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Allstate. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Allstate compared to the broader market.
- Price Targets: Understanding forecasts, analysts offer estimates for Allstate's future value. Examining the current and prior targets provides insight into analysts' changing expectations.
Capture valuable insights into Allstate's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on Allstate analyst ratings.
Get to Know Allstate Better
Allstate is one of the largest U.S. property and casualty insurers in the U.S. Personal auto represents the largest percentage of revenue, but the company offers homeowners insurance and other insurance products. Allstate products are sold in North America primarily by about 10,000 company agencies.
Allstate's Financial Performance
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: Allstate's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2023, the company achieved a revenue growth rate of approximately 9.76%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Allstate's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -0.28%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Allstate's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -0.31%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Allstate's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -0.04%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Allstate's debt-to-equity ratio stands notably higher than the industry average, reaching 0.63. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
Analyst Ratings: Simplified
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
